Radiating Progress: Cutting-Edge Theranostics for Cancer Management

Categories: Oncology
Wishlist Share
Share Course
Page Link
Share On Social Media

Course Content

Preclinical evaluation of [203/212Pb]Pb-PSV359 for in vivo animal imaging and alpha-particle therapy of cancers expressing fibroblast activation protein (FAP)

  • Abstract
    00:00
  • Preclinical evaluation of [203/212Pb]Pb-PSV359 for in vivo animal imaging and alpha-particle therapy of cancers expressing fibroblast activation protein (FAP)
    12:33

Preclinical evaluation of novel copper-64/67 radiolabeled theranostic peptides targeting the integrin αvβ6

Preclinical Evaluation of a Zinc Phthalocyanine (ZnPc) Integrin αvβ6-targeted Photodynamic Therapy Agent

Optimizing Radiometallated-Peptides Synthetic using Zwitterions for Targeted Radionuclide Therapy

Pretargeting with the matched pair 64/67Cu for a Theranostic Approach in a Pancreatic Cancer Mouse Model

Development of a Radioimmunotherapy against Nectin-4 for the Management of Head and Neck Cancer